LT3380104T - A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti - Google Patents

A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti

Info

Publication number
LT3380104T
LT3380104T LTEP16806299.0T LT16806299T LT3380104T LT 3380104 T LT3380104 T LT 3380104T LT 16806299 T LT16806299 T LT 16806299T LT 3380104 T LT3380104 T LT 3380104T
Authority
LT
Lithuania
Prior art keywords
ecopic
treatment
receptor ligand
adenosine receptor
fat accumulation
Prior art date
Application number
LTEP16806299.0T
Other languages
English (en)
Inventor
Pnina Fishman
Shira Cohen
Original Assignee
Can-Fite Biopharma Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Can-Fite Biopharma Ltd. filed Critical Can-Fite Biopharma Ltd.
Publication of LT3380104T publication Critical patent/LT3380104T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTEP16806299.0T 2015-11-23 2016-11-22 A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti LT3380104T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL242723A IL242723B (en) 2015-11-23 2015-11-23 A3 adenosine receptor ligand for the treatment of ectopic fat accumulation
PCT/IL2016/051258 WO2017090036A1 (en) 2015-11-23 2016-11-22 An a3 adenosine receptor ligand for use in treating ectopic fat accumulation

Publications (1)

Publication Number Publication Date
LT3380104T true LT3380104T (lt) 2021-05-10

Family

ID=57485841

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16806299.0T LT3380104T (lt) 2015-11-23 2016-11-22 A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti

Country Status (19)

Country Link
US (2) US10780106B2 (lt)
EP (1) EP3380104B1 (lt)
JP (2) JP6980655B2 (lt)
KR (1) KR102103657B1 (lt)
CN (1) CN108367016B (lt)
BR (1) BR112018010391A8 (lt)
CA (1) CA3005961C (lt)
DK (1) DK3380104T3 (lt)
ES (1) ES2848150T3 (lt)
HR (1) HRP20210020T1 (lt)
HU (1) HUE053558T2 (lt)
IL (3) IL242723B (lt)
LT (1) LT3380104T (lt)
MX (1) MX378107B (lt)
PL (1) PL3380104T3 (lt)
PT (1) PT3380104T (lt)
RS (1) RS61372B1 (lt)
SI (1) SI3380104T1 (lt)
WO (1) WO2017090036A1 (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL254535A0 (en) * 2017-09-17 2017-11-30 Can Fite Biopharma Ltd Adenosine a3 receptor ligand for use in the management of cytokine release syndrome
IL264112A (en) * 2019-01-06 2020-07-30 Fishman Pnina An a3 adenosine receptor ligand for use for reducing level of adipocytes
IL272078A (en) 2020-01-16 2021-07-29 Can Fite Biopharma Ltd Cannabinoids for use in treatment
CN121045296A (zh) 2024-05-31 2025-12-02 康菲特生物制药有限公司 制备纳莫德诺森的工艺

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443836A (en) 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
WO1995002604A1 (en) 1993-07-13 1995-01-26 The United States Of America, Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists
US5688774A (en) 1993-07-13 1997-11-18 The United States Of America As Represented By The Department Of Health And Human Services A3 adenosine receptor agonists
WO1997027173A2 (en) 1996-01-24 1997-07-31 Sumitomo Chemical Company, Limited Dihalopropene compounds, their use as insecticides/acaricides and intermediates for their production
JP2003517423A (ja) 1997-07-29 2003-05-27 メドコ リサーチ、インコーポレイテッド アデノシンレセプターモジュレーターとしてのｎ６−置換アデノシン−５′−ウロナミド
US6048865A (en) 1997-07-29 2000-04-11 Medco Research, Inc. N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator
AU1363699A (en) 1997-10-23 1999-05-10 National Institute Of Health Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents
IL133680A0 (en) 1999-09-10 2001-04-30 Can Fite Technologies Ltd Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
US7589075B2 (en) 2001-01-16 2009-09-15 Can-Fite Biopharma Ltd. Use of an adenosine A3 receptor agonist for inhibition of viral replication
EP1983990B1 (en) 2006-01-26 2011-03-23 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services A3 adenosine receptor allosteric modulators
JP5592262B2 (ja) * 2007-10-15 2014-09-17 キャン−ファイト・バイオファーマ・リミテッド 肝細胞の増殖を誘導する方法及びその使用
JP2015504088A (ja) * 2012-01-23 2015-02-05 キャン−ファイト バイオファーマ リミテッドＣａｎ−Ｆｉｔｅ ＢｉｏＰｈａｒｍａ Ｌｔｄ． 肝疾患の治療

Also Published As

Publication number Publication date
IL242723A0 (en) 2016-02-29
WO2017090036A1 (en) 2017-06-01
US20200384009A1 (en) 2020-12-10
IL259396B (en) 2022-02-01
MX378107B (es) 2025-03-10
CA3005961C (en) 2024-06-04
IL259396A (en) 2018-07-31
MX2018006026A (es) 2019-01-28
JP2018534333A (ja) 2018-11-22
JP6990934B2 (ja) 2022-01-12
IL289841A (en) 2022-03-01
CA3005961A1 (en) 2017-06-01
US10780106B2 (en) 2020-09-22
RS61372B1 (sr) 2021-02-26
SI3380104T1 (sl) 2021-05-31
HRP20210020T1 (hr) 2021-03-05
JP2020090532A (ja) 2020-06-11
KR102103657B1 (ko) 2020-04-23
DK3380104T3 (da) 2021-02-08
PT3380104T (pt) 2021-02-05
PL3380104T3 (pl) 2021-08-02
BR112018010391A8 (pt) 2019-02-26
IL242723B (en) 2019-12-31
HUE053558T2 (hu) 2021-07-28
ES2848150T3 (es) 2021-08-05
KR20180081595A (ko) 2018-07-16
BR112018010391A2 (pt) 2018-11-21
IL289841B (en) 2022-07-01
EP3380104B1 (en) 2020-11-11
EP3380104A1 (en) 2018-10-03
US20180264022A1 (en) 2018-09-20
US11291681B2 (en) 2022-04-05
CN108367016B (zh) 2021-07-16
JP6980655B2 (ja) 2021-12-15
CN108367016A (zh) 2018-08-03

Similar Documents

Publication Publication Date Title
DK3368060T3 (da) Glugacon-receptor-agonister
EP3314027A4 (en) THERAPEUTIC OLIGONUCLEOTIDES
DK3265421T3 (da) Doseringssystem
EP3313239A4 (en) BACK SUPPORT
HUE059158T2 (hu) Eljárás pridopidin elõállítására
LT3390390T (lt) Bipirazolilo dariniai, tinkami naudoti autoimuninių ligų gydymui
EP3282899A4 (en) SEAT ARRANGEMENT
EP3376976A4 (en) TROKARTRÄGER
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3451888T3 (da) Gulvbehandlingssystem
EP3297102A4 (en) Connector
EP3300502A4 (en) PROCESS FOR PREPARING VITAMIN A OLIGOSACCHARIDES AND METHOD FOR THE PRODUCTION THEREOF
DK3294769T3 (da) Behandling for multipelt myelom (mm)
DK3451886T3 (da) Gulvbehandlingssystem
DK3166473T3 (da) Oftalmoskoper
LT3113778T (lt) Piridazino dariniai, skirti naudoti ataksinio sutrikimo profilaktikai arba gydymui
GB201504915D0 (en) Ophthalmoscope
EP3305185A4 (en) SPHYGMOMANOMETER
LT3380104T (lt) A3 adenozino receptoriaus ligandas, skirtas ektopiniam riebalų kaupimuisi gydyti
DK3329004T3 (da) Terapeutiske oligonukleotider
DK3795130T3 (da) Terapiapparat.
FR3042172B1 (fr) Siege reglable
ES1100308Y (es) Prenda de vestir para bebes.
IT201600069848A1 (it) Friggitrice.
FR3043700B1 (fr) Non tisse